These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 26869691)
21. PCR based detection of tcdCΔ117 in Clostridium difficile infection identifies patients at risk for recurrence - A hospital-based prospective observational study. Jazmati N; Hain O; Hellmich M; Plum G; Kaasch A Anaerobe; 2019 Jun; 57():39-44. PubMed ID: 30878603 [TBL] [Abstract][Full Text] [Related]
22. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics. van Werkhoven CH; van der Tempel J; Jajou R; Thijsen SF; Diepersloot RJ; Bonten MJ; Postma DF; Oosterheert JJ Clin Microbiol Infect; 2015 Aug; 21(8):786.e1-8. PubMed ID: 25889357 [TBL] [Abstract][Full Text] [Related]
24. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. Li Y; Qian J; Queener E; Shen B Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770 [TBL] [Abstract][Full Text] [Related]
25. Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection. Chandra S; Thapa R; Marur S; Jani N J Clin Gastroenterol; 2014; 48(5):419-22. PubMed ID: 24172178 [TBL] [Abstract][Full Text] [Related]
26. Clinical Impact of Clostridium difficile PCR Cycle Threshold-Predicted Toxin Reporting in Pediatric Patients. Schwenk HT; Bio LL; Kruger JF; Banaei N J Pediatric Infect Dis Soc; 2020 Feb; 9(1):44-50. PubMed ID: 30476169 [TBL] [Abstract][Full Text] [Related]
27. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. Lamousé-Smith ES; Weber S; Rossi RF; Neinstedt LJ; Mosammaparast N; Sandora TJ; McAdam AJ; Bousvaros A J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):293-7. PubMed ID: 23698022 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of Clostridium difficile toxinotypes in infected patients at a tertiary care center in Lebanon. Moukhaiber R; Araj GF; Kissoyan KA; Cheaito KA; Matar GM J Infect Dev Ctries; 2015 Jul; 9(7):732-5. PubMed ID: 26230123 [TBL] [Abstract][Full Text] [Related]
29. Use of a Perianal Swab Compared With a Stool Sample to Detect Symptomatic Clostridium difficile Infection. Montecalvo MA; Sisay E; McKenna D; Wang G; Visintainer P; Wormser GP Infect Control Hosp Epidemiol; 2017 Jun; 38(6):658-662. PubMed ID: 28376944 [TBL] [Abstract][Full Text] [Related]
30. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes. Hitchcock MM; Holubar M; Hogan CA; Tompkins LS; Banaei N J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511334 [TBL] [Abstract][Full Text] [Related]
31. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ; Euro Surveill; 2015; 20(38):. PubMed ID: 26536049 [TBL] [Abstract][Full Text] [Related]
32. Application of Nuclear Magnetic Resonance to Detect Toxigenic Clostridium difficile from Stool Specimens: A Proof of Concept. Yang P; Hash S; Park K; Wong C; Doraisamy L; Petterson J; Petti CA; Ward PM; Lee SH; Menon S; She RC J Mol Diagn; 2017 Mar; 19(2):230-235. PubMed ID: 28081922 [TBL] [Abstract][Full Text] [Related]
33. Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results? Sunkesula VC; Kundrapu S; Muganda C; Sethi AK; Donskey CJ Clin Infect Dis; 2013 Aug; 57(4):494-500. PubMed ID: 23645849 [TBL] [Abstract][Full Text] [Related]
35. Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)? Berry CE; Davies KA; Owens DW; Wilcox MH Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2405-2415. PubMed ID: 28780742 [TBL] [Abstract][Full Text] [Related]
36. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Deshpande A; Pasupuleti V; Patel P; Ajani G; Hall G; Hu B; Jain A; Rolston DD Clin Gastroenterol Hepatol; 2011 Aug; 9(8):665-669.e1. PubMed ID: 21635969 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis. Deshpande A; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Pant C; Hernandez AV Clin Infect Dis; 2011 Oct; 53(7):e81-90. PubMed ID: 21890762 [TBL] [Abstract][Full Text] [Related]
38. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area. Shin BM; Lee EJ; Kuak EY; Yoo SJ Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927 [TBL] [Abstract][Full Text] [Related]
39. Comparison of testing approaches for Clostridium difficile infection at a large community hospital. Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523 [TBL] [Abstract][Full Text] [Related]